Research Article
Potential Association of Body Constitution with the Prognosis of IgA Nephropathy: A Long-Time Follow-Up of 203 Cases in China
Table 3
Clinical characteristics at biopsy and follow-up for patients with Yang-deficiency BC and non-Yang-deficiency BC.
| | Characteristics | Yang-deficiency BC (n=97) | Non-Yang-deficiency BC (n=106) | P values |
| | Age (years) | 41.0±10.9 | 39.2±12.1 | 0.271 | | Male (n (%)) | 44 (45.4) | 67 (63.2) | 0.011 | | BMI (kg/m2) | 24.2±4.0 | 24.7±3.4 | 0.386 | | Smoking (n (%)) | 20(20.6) | 27(25.5) | 0.413 | | Alcohol drinking (n (%)) | 18(18.6) | 24(22.6) | 0.473 | | Less exercise (n (%)) | 26(26.8) | 26(24.5) | 0.711 | | MAP(mmHg) | 99.1±13.8 | 97.3±12.6 | 0.352 | | Urinary protein (g/d) | 1.78±1.80 | 1.58±1.32 | 0.398 | | Serum albumin (g/L) | 37.4±6.0 | 39.6±5.5 | 0.009 | | eGFR (ml/min) | 80.2±29.0 | 80.3±28.7 | 0.985 | | Serum uric acid (μmol/L) | 374.2±97.6 | 389.7±103.7 | 0.275 | | CKD stage (n (%)) | | | 0.989 | | stage 1 | 43(44.3) | 45(42.5) | | | stage 2 | 26(26.8) | 29(27.4) | | | stage 3 | 25(25.8) | 28(26.4) | | | stage 4 | 3(3.1) | 4(3.8) | | | (n (%)) | 45(46.4) | 58(54.7) | 0.236 | | Follow-up (months) | 64.6±17.8 | 63.4±14.5 | 0.600 | | Endpoint event (n (%)) | 23(23.7) | 9(8.5) | 0.003 |
|
|
Corticosteroid and/or immunosuppressant treatments; BMI: body mass index; MAP: mean arterial pressure; eGFR: estimated glomerular filtration rate; CKD: chronic kidney disease; endpoint event: 50% decline in eGFR or end-stage renal disease. |
